Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Esomeprazole Capsules vs Tablets
NCT03083639Phase 1Completed
- Sponsor
- Takeda
- Start
- Mar 2017
- Primary completion
- May 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of esomeprazole in gastroesophageal reflux disease (GERD) (2 arms), sponsored by Takeda. Primary endpoints: Area Under the Plasma Concentration-time Curve From Time 0 to Infinity, Area Under the Plasma Concentration-time Curve From Time 0 to Time t and 1 more. Started Mar 2017; status: completed.
02
Drugs
esomeprazole
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on NCT03083639.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03083639.